As of February 9th 2009, Resnova will distribute PathoFinder’s in vitro diagnostic kits used for rapid detection and differentiation of multiple pathogens in Italy. Resnova will handle all sales, marketing, and support for the PathoFinder products under the exclusive agreement.
“Resnova’s extensive knowledge of molecular biology technologies, especially PCR and MLPA, and their ability to quickly and efficiently train their customers in the implementation of new techniques makes them a perfect partner for us”, according to Dr. Guus Simons, CEO of PathoFinder.